Introduction
The hexacyclic aromatic hydrocarbon dibenzo [a,l] pyrene (DB[a,l]P) (Figure 1 ) is the most highly tumorigenic polycyclic aromatic hydrocarbon (PAH) tested to date. The tumorinitiating activity of DB[a,l]P exceeds that of benzo [a] pyrene (B[a]P) and even of 7,12-dimethylbenz[a]anthracene (DMBA), formerly thought to be the most potent carcinogenic PAH after application to mouse skin or rat mammary gland (1) (2) (3) . DB[a,l]P has been detected as a widespread pollutant in the human environment (4) (5) (6) (7) (8) , and several laboratories have investigated the mechanism of DNA damage induction by this compound. Studies in mammalian cell cultures including human cell lines (9, 10) , in mouse skin in vivo (9) , and in microsomal preparations (11) revealed that cytochrome P450 enzymes activate DB[a,l]P to its electrophilically reactive fjord region 11,12-dihydrodiol 13,14-epoxides (DB[a,l]PDEs) ( Figure 1 ) which predominantly bind to deoxyadenosine residues within DNA. Analysis of the stereochemical course of the metabolic activation in human mammary carcinoma MCF-7 cells (10) 
demonstrated that this PAH is exclusively converted to (ϩ)-syn-(11S,12R,13S,14R)-and (-)-anti-(11R,12S, 13S,14R)-DB[a,l]PDE via their corresponding precursors, the (ϩ)-(11S,12S)-and (-)-(11R,12R)-dihydrodiols, respectively (Figure 1). No formation of (ϩ)-anti-(11S,12R,13R,14S)-and (-)-syn-(11R,12S,13R,14S)-DB[a,l]PDE was detected (10).
Although only racemic fjord region syn-and anti-DB [a,l] PDEs have been tested, their extraordinarily strong mutagenic activity in Salmonella typhimurium and Chinese hamster V79 cells (12) , and their high carcinogenic potency in mouse skin, newborn mouse and rat mammary gland (13) (14) (15) may account for the high tumorigenicity of DB[a,l]P. Although it has been proposed that DB[a,l]P can also be activated through a radical cation intermediate to produce unstable depurinating DNA adducts (11) , no increase in apurinic sites was detected in MCF-7 cells exposed to DB[a,l]P and its 11,12-dihydrodiol 13,14-epoxides (16) . The DNA damage induced in MCF-7 cells treated with DB[a,l]P results from the formation of stable covalent DB[a,l]PDE-DNA adducts only (16) .
Covalent modification of genomic DNA by metabolically formed DB[a,l]PDEs (10, 11, 17, 18) represents a type of cellular DNA damage demonstrated previously to be responsible for an increase in the tumor suppressor protein p53. Cells containing wild-type p53 phosphoprotein are able to recognize DNA damage caused not only by metabolites of PAH (19) (20) (21) (22) , but also by UV light (23) , ionizing radiation (24) or antitumor drugs (25) . The initial cellular response consists of a nuclear accumulation of p53, transcriptional induction of various target genes containing p53-binding domains, and subsequent cell-cycle arrest, usually in G 1 (24, 26) . Within this signal cascade the cyclin-dependent kinase (CDK) inhibitor p21 WAF1 is an important mediator of the p53-induced cellcycle arrest (26, 27) . Evidence that p53 is involved in DNA repair (28, 29) and the induction of apoptosis (26, 30) led to recognition that p53 participates in a signal transduction pathway which recognizes DNA damage and which can subsequently lead to growth arrest until DNA damage is repaired or programed cell death has been initiated (31). In contrast, cells which contain a mutated p53 gene, even if they express high constitutive levels of its protein product, lack a comparable response to DNA damage (21, 24) and are more suceptible to the induction of mutations and development of transformed cell clones. The high prevalence of p53 gene mutations found in human cancers is consistent with this role for the p53 protein (32) .
In order to determine how specific PAH-DNA adduct levels determine the cellular response to PAH-DNA damage, wildtype p53-expressing mammary adenocarcinoma-derived MCF-7 cells (33) were treated with (ϩ)-syn-and (-)-anti-DB[a,l]PDE and levels of DNA adducts in conjunction with those of the tumor suppressor protein p53 and the CDK inhibitor p21 WAF1 were measured over a 96 h period after exposure. All adducts were identified by cochromatography with synthetic standards as previously described (10) . 33 P-post-labeling and separation on HPLC was performed as described in Materials and methods.
Materials and methods

Chemicals
aprotinin, and the trypsin-chymotrypsin protease inhibitor (TCPI) were obtained from Boehringer Mannheim. Phosphate-buffered saline (PBS) contained 3.0 mM KCl, 1.5 mM KH 2 PO 4 , 140 mM NaCl, 8.0 mM Na 2 HPO 4 (pH 7.4). Acrylamide and bisacrylamide for gel electrophoresis were purchased as a 40% mixture (w/v) from Bio-Rad (Hercules, CA). Preparation of enantiomeric 11,12-dihydrodiols of DB[a,l]P as described previously (17) allowed subsequent generation of optically pure (ϩ)-syn-and (-)-anti-DB[a,l]PDEs using the same synthetic route described for the racemic compounds (12) .
Cell culture
The human mammary carcinoma cell line MCF-7 (original stock line was obtained from the Michigan Cancer Foundation) was grown in 175 cm 2 cell culture flasks in a total volume of 50 ml of Dulbecco's modified Eagle's medium, high glucose type (DMEM with 4.5 g D-glucose/l; Gibco BRL, Grand Island, NY), supplemented with 10% fetal calf serum (FCS; Intergen, Purchase, NY), 0.1 mM non-essential amino acids (Gibco BRL) and 1 mM sodium pyruvate (Gibco BRL).
Treatment of MCF-7 cells with (ϩ)-syn-and (-)-anti-DB[a,l]PDE
After MCF-7 cells covered~50-60% of the surface area of the flasks (2-3 days after splitting of a confluent culture), the media was removed and the cells were washed twice with 20 ml sterile PBS. Medium without FCS (50 ml) was added to the flask, then 30 µl of a dimethyl sulfoxide (DMSO) solution of the enantiomerically pure (ϩ)-syn-or (-)-anti-DB[a,l]PDE was added. an equal volume of medium containing 10% FCS, the cells were centrifuged at 1000 g, washed twice with PBS, and the cell pellet stored at -80°C. DNA preparation DNA isolation from MCF-7 cell pellets was carried out as described previously (10) . Briefly, the cell pellets were homogenized in EDTA-sodium dodecyl sulfate (SDS) buffer [10 mM Tris, 1 mM Na 2 EDTA, 1% SDS (w/v), pH 8] and incubated for 1 h at 37°C with RNase T1 (1000 U/ml) and RNase (DNase free; 5 µg/ml) on a shaker (100 r.p.m.). Then proteinase K (500 µg/ml) was added and the incubation continued for 1 h at 37°C. The mixture was extracted twice with 1 vol Tris-saturated phenol (1 M, pH 8.0) then twice with Trissaturated phenol/chloroform/iso-amyl alcohol (25:24:1, v/v/v). The DNA was precipitated with 2 vol ethanol and 0.1 vol 5 M NaCl, washed with 70% ethanol, dried and dissolved in water. The DNA concentration in the solution was determined by A 260 nm . 33 
P-post-labeling of DB[a,l]PDE-DNA adducts
Post-labeling was carried out as described previously (10) . An aliquot of 10 µg DB[a,l]PDE-DNA was digested, post-labeled with [γ-33 P]ATP (3500 Ci/ mmol) and pre-purified with a Sep-Pak C 18 cartridge (Waters, Milford, MA). Adducts were separated by HPLC on a C 18 reverse-phase column (5 µm Ultrasphere ODS, 4.6ϫ250 mm; Beckman Instruments) and the radiolabeled nucleotides measured with an on-line radioisotope flow-detector (Radiomatic FLO-ONE Beta; Packard Instruments, Downers Grove, IL). The level of DNA binding (reported as pmol adducts/mg DNA) was calculated based upon the efficiency of labeling of a B[a]P-7,8-dihydrodiol 9,10-epoxide-DNA standard as described previously (34) .
Isolation and western blotting of MCF-7 cell protein preparations
Total proteins from MCF-7 cells treated with (ϩ)-syn-or (-)-anti-DB[a,l]PDE were isolated according to the protocol described by Harlow and Lane (35) . Briefly, the frozen cell pellet was diluted in an appropriate volume of RIPA lysis buffer [150 mM NaCl, 10 mM Tris-HCl (pH 7.2), 1% sodium desoxycholate (w/v), 1% Triton X-100 (v/v), 0.1% SDS (w/v)] (~1 ml/10 7 cells). Prior to addition to the cells the RIPA buffer was pre-chilled to 4°C and the following were added per ml solution: 50 µl of 0.1 M Na 2 EDTA (pH 8.0) and 10 µl of each of the protease inhibitors leupeptin (1 mg/ml stock in water), PMSF (100 mM stock in iso-propanol), aprotinin (1 mg/ml stock in PBS) and TCPI (1 mg/ml stock in PBS). The buffer-cell mixture was aspirated through a fine-gauge needle (25 gauge fixed on a 1 ml syringe), then boiled in a water bath until an aggregate of sheared DNA and cell fragments had formed (~10 min). After cooling on ice, soluble proteins were separated by centrifugation at 10 000 g for 10 min. The protein concentration in this solution was spectrophotometrically determined at 562 nm using the Bicinchoninic acid colorimetric assay of Pierce (Rockford, IL). Lysates of A431 cells (human squamous carcinoma cell line) obtained from the Purdue University cell culture laboratory were also prepared for use as a p53-positive control in western blot analysis (36) . These cells contain high amounts of p53 protein due to mutations in codons 248 and 273 of the corresponding gene which result in increased stability of the protein (37) .
Prior to the western blotting, an appropriate amount of each isolated protein sample (40 µg) was diluted in loading buffer [10% glycerol (v/v), 5% 2-mercaptoethanol (v/v), 0.16 M Tris (pH 6.8), 3% SDS (w/v), 0.06% bromophenol blue (w/v)] and separated by SDS-polyacrylamide gel electrophoresis (PAGE) (0.1% SDS, 10% acrylamide) using the following electrode buffer: incubation with the primary antibody the blot was washed twice with TBSTween for 10 min each and then incubated for 1 h at room temperature with the secondary antibody (goat anti-mouse IgG linked to horseradish peroxidase) diluted in TBS-Tween. The membranes were washed three times with TBSTween and the proteins were detected using the enhanced chemiluminescence technique (Amersham). Protein lysates from A431 cells were used as a positive control for p53. Figure  1 ) in order to determine how DNA adduct formation affected the cellular content of the tumor suppressor p53 protein and the CDK-inhibitor p21 WAF1 . The HPLC elution profiles of the 33 P-post-labeled DNA adducts formed in MCF-7 cells after treatment with 0.03 µM (ϩ)-syn-and (-)-anti-DB[a,l]PDE are shown in Figure 2 . The DNA from MCF-7 cells treated with (ϩ)-syn-DB[a,l]PDE contained two major adduct peaks that eluted at 70 and 102 min. These have previously been identified as dA adducts by cochromatography with synthetic standards (10) . The DNA from MCF-7 cells treated with (-)-anti-DB[a,l]PDE contained three major adduct peaks. The large peak eluted at 78 min is a dA adduct and the smaller peaks eluted at 62 and 68 min are dG adducts (10) . At all doses of these dihydrodiol epoxides tested, the proportions of the DNA adducts present were similar; however, the absolute amounts of DNA adducts varied with the dose of dihydrodiol epoxides.
Results
Human mammary carcinoma MCF-7 cells were treated with enantomerically pure (ϩ)-syn-or (-)-anti-DB[a,l]PDE (
The level of DNA binding and amount of p53 protein in MCF-7 cells observed 8 h after treatment with increasing concentrations of (ϩ)-syn-and (-)-anti-DB[a,l]PDE are shown in Figure 3 that gave at least 15 pmol adducts/mg DNA caused similar increases in p53 and p21 WAF1 protein levels.
Discussion
The strong carcinogen DB[a,l]P has been found to exert its genotoxic activity in human mammary MCF-7 cells predominantly via metabolic activation to (ϩ)-syn-and (-)-anti-DB[a,l]PDE which react with genomic DNA to form mainly deoxyadenosine adducts (10, 16) (Figure 4) . The significantly lower DNA adduct level observed after exposure to equimolar concentrations of (ϩ)-syn-DB[a,l]PDE compared with (-)-anti-DB[a,l]PDE might be due to increased sequestration of the syn-diastereomer as a consequence of its preferentially adopted aligned conformation (12) . Vicinal syn-dihydrodiol epoxides preferring this conformation have been shown to undergo significantly accelerated solvolytic opening of their oxiranyl ring under neutral conditions compared with corresponding anti-diastereomers (38) . This explanation would also be consistent with the observation that (ϩ)-syn-DB[a,l]PDE-DNA adducts were only detected in MCF-7 cells after treatment with high doses of the parent PAH (1-8 µM), whereas (-)-anti-DB[a,l]PDE-DNA adducts were present at detectable levels after exposure to a dose as low as 0.005 µM DB[a,l]P (39).
DNA damage induced by both DB[a,l]PDEs increased the cellular content of the p53 protein 8 h after exposure ( Figure  3) . Therefore, DB[a,l]PDE-DNA adducts caused a similar increase in p53 protein levels in MCF-7 cells as has been observed in various human cell cultures treated with a number of DNA-damaging agents including ionizing radiation (24) , antitumor drugs (25) and metabolites of other PAHs (19, 21, 22) . Others have demonstrated in various wild-type p53-expressing human cell lines that DNA damage leads to nuclear accumulation of this protein followed by induction of p21 WAF1 and subsequent cell-cycle arrest in G 1 (24, 26, 27, 40) . In addition to this p53-dependent signal transduction pathway via induction of p21 WAF1 , evidence has been found for p53-independent induction of p21 WAF1 caused by DNA damage (41) . The results obtained after treatment of MCF-7 cells with 0.01 µM (ϩ)-syn-DB[a,l]PDE ( Figure 5 ) may involve such a pathway. Although no increase in p53 was observed at any time after treatment up to 96 h, a considerable increase in p21 WAF1 protein was detected by 12 h after exposure and maintained for 4 days.
The CDK-inhibitor p21 WAF1 inhibits both the cyclin-dependent G 1 kinases and the G 2 /M-specific cdc2 kinase (42, 43) . A number of types of DNA damage have been demonstrated to cause G 1 arrest controlled by a wild-type p53-dependent induction of p21 WAF1 (21, 24, 44) . However, DNA damage can also result in an arrest in G 2 . DNA damage induced by γ-irradiation has been found to induce G 2 /M accumulation of cells that lack wild-type p53 expression (24, 45) . Up-regulation of wild-type p53 gene expression in human fibroblasts in the absence of any DNA damaging agent has also been shown to result in the mediation of a reversible growth arrest by both the control of the G 1 and the G 2 /M checkpoints (45) . In both cases, the arrest was associated with high levels of p21 WAF1 (45) .
Measurement of the p21 WAF1 content in MCF-7 cells after treatment with 0.005 µM DB[a,l]P (39) or different doses of (-)-anti-and (ϩ)-syn-DB[a,l]PDE (Figures 5 and 6 'stealth carcinogens' by allowing replication prior to cell-cycle arrest has been proposed by Khan et al. (22) . Although they observed cell-cycle arrest in S phase with only a small increase in p21 WAF1 protein levels in cells treated with racemic anti-11,12-dihydrodiol 13,14-epoxide of benzo[g]chrysene, the 21 h time-point tested may have been early in the p21 WAF1 response (22) . In studies with DB[a,l]P (39) (Figures 5 and 6 ).
The present study demonstrates that there is a dosedependent increase in p53 protein levels in MCF-7 cells after exposure to (ϩ)-syn-or ( (19) indicate that the increase of wild-type p53 protein levels is related to formation of a critical level of adducts rather than by specific adduct structures and configurations. The results demonstrate that formation of DB[a,l]PDE-DNA adducts also causes a long-term induction of the CDK inhibitor p21 WAF1 . The presence of an increase in p21 WAF1 protein levels in the absence of a detectable increase in p53 protein levels in cells treated with 0.01 µM (ϩ)-syn-DB[a,l]PDE suggests that p53-independent induction of p21 WAF1 can also result from DB[a,l]PDE-DNA adduct formation. The long term induction of p21 WAF1 after formation of DB[a,l]PDE-DNA adducts may lead to G 2 /M arrest, which remains to be further established.
